Midori Ishii

725 total citations
41 papers, 518 citations indexed

About

Midori Ishii is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Midori Ishii has authored 41 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 9 papers in Immunology. Recurrent topics in Midori Ishii's work include CAR-T cell therapy research (8 papers), Sarcoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (5 papers). Midori Ishii is often cited by papers focused on CAR-T cell therapy research (8 papers), Sarcoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (5 papers). Midori Ishii collaborates with scholars based in Japan, United States and India. Midori Ishii's co-authors include Yoshiyuki Suehara, Tsuyoshi Saito, Keisuke Akaike, Kazuo Kaneko, Kenta Mukaihara, Tatsuya Takagi, Taketo Okubo, Daisuke Kubota, Takashi Yao and Hiromitsu Nakauchi and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Midori Ishii

36 papers receiving 503 citations

Peers

Countries citing papers authored by Midori Ishii

Since Specialization

Citations

This map shows the geographic impact of Midori Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Midori Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Midori Ishii more than expected).

Fields of papers citing papers by Midori Ishii

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Midori Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Midori Ishii. The network helps show where Midori Ishii may publish in the future.

Co-authorship network of co-authors of Midori Ishii

This figure shows the co-authorship network connecting the top 25 collaborators of Midori Ishii. A scholar is included among the top collaborators of Midori Ishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Midori Ishii. Midori Ishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Eleven cases of laryngeal edema after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas 2024 ·Haematologica ·(unknown), (unknown), (unknown), (unknown), Yuko Toyoshima, (unknown), (unknown), Eriko Sato, (unknown), (unknown), Naoki Watanabe, Tomoiku Takaku, Hajime Yasuda, (unknown), Makoto Sasaki, Shuko Nojiri, Midori Ishii, Miki Ando	0
2	Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung Cancer 2024 ·Cancer Research Communications ·(unknown), Midori Ishii, (unknown), Takaharu Kimura, Tomoyuki Yamaguchi, (unknown), (unknown), Kazutaka Nakashima, Yozo Nakazawa, Satoshi Yamazaki, Koichi Ohshima, Kazuhisa Takahashi, Hiromitsu Nakauchi, Miki Ando	7
3	iPSC-Derived CD4 T Cell Generation and Investigation of CD4/CD8 T Cell Lineage Choice 2023 ·Blood ·(unknown), Midori Ishii, (unknown), (unknown), Jun Ando, Hiromitsu Nakauchi, Miki Ando	3
4	iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer 2023 ·Cell Reports Medicine ·(unknown), Midori Ishii, Jun Ando, Kazuya Ikeda, Kyomi J. Igarashi, (unknown), (unknown), (unknown), (unknown), Mahito Nakanishi, Koichi Ohshima, (unknown), (unknown), Mari Kitade, Matthew H. Porteus, Yasuhisa Terao, Hiromitsu Nakauchi, Miki Ando	10
5	Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis 2023 ·Experimental Hematology ·Ai Sato, Midori Ishii, Kota Tachibana, (unknown), (unknown), (unknown), (unknown), Jun Ando, Miki Ando	1
6	Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma 2023 ·Cancer Chemotherapy and Pharmacology ·Hajime Yasuda, Naoko Kaga, Hikari Taka, Tomonori Ochiai, (unknown), Yoshiki Miura, Midori Ishii, Makoto Sasaki, Jun Ando, Miki Ando	0
7	iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma 2021 ·Cancer Immunology Research ·Midori Ishii, Jun Ando, Satoshi Yamazaki, (unknown), (unknown), (unknown), Yoshiyuki Suehara, Mahito Nakanishi, Kazutaka Nakashima, Koichi Ohshima, Hiromitsu Nakauchi, Miki Ando	17
8	SCLC-J1, a novel small cell lung cancer cell line 2021 ·Biochemistry and Biophysics Reports ·(unknown), (unknown), Jun Ando, (unknown), Midori Ishii, (unknown), Yoichiro Mitsuishi, Tetsuhiko Asao, Ken Tajima, Taketsugu Yamamoto, Fumiyuki Takahashi, Norio Komatsu, Kazuhisa Takahashi, Miki Ando	4
9	Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma 2021 ·Molecular Therapy ·(unknown), Miki Ando, Jun Ando, Midori Ishii, Tomoyuki Yamaguchi, Satoshi Yamazaki, (unknown), (unknown), Manami Ohtaka, Mahito Nakanishi, (unknown), Yasunori Ota, Kazutaka Nakashima, Koichi Ohshima, Chihaya Imai, Yozo Nakazawa, Hiromitsu Nakauchi, Norio Komatsu	29
10	Trigenic ADH5/ALDH2/ADGRV1 mutations in myelodysplasia with Usher syndrome 2021 ·Heliyon ·(unknown), Miki Ando, Jun Ando, Midori Ishii, (unknown), (unknown), (unknown), Shuichi Shirane, Yoshihito Kishita, Yukiko Yatsuka, Hidetaka Eguchi, Yasushi Okazaki, Norio Komatsu	3
11	Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers 2020 ·Molecular Therapy ·(unknown), Miki Ando, Jun Ando, Midori Ishii, (unknown), (unknown), (unknown), Manami Ohtaka, (unknown), Yasuhisa Terao, Mahito Nakanishi, Hiromitsu Nakauchi, Norio Komatsu	21
12	Long-term eradication of extranodal natural killer/T-cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells in vivo 2019 ·Haematologica ·Miki Ando, Jun Ando, Satoshi Yamazaki, Midori Ishii, (unknown), (unknown), (unknown), Tomoyuki Yamaguchi, Masanori Nojima, Koichi Ohshima, Hiromitsu Nakauchi, Norio Komatsu	16
13	The Development of the Short-form of “25-Question Geriatric Locomotive Function Scale” 2018 ·Journal of Advances in Medicine and Medical Research ·(unknown), Yoshiyuki Suehara, (unknown), Shuko Nojiri, Taketo Okubo, Midori Ishii, Takayuki Kawasaki, (unknown), Keisuke Akaike, Kenta Mukaihara, (unknown), Tsuyoshi Saito, Kazuo Kaneko	7
14	A case of secondary chondrosarcoma with TP53 mutation arising from fibrous dysplasia 2016 ·International Journal of Clinical and Experimental Pathology ·(unknown), Keisuke Akaike, (unknown), Midori Ishii, (unknown), Tsuyoshi Saito, Yoshiyuki Suehara, Tatsuya Takagi, Kazuo Kaneko, (unknown)	0
15	Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma 2016 ·BMC Cancer ·Kenta Mukaihara, Yoshiyuki Suehara, Shinji Kohsaka, Daisuke Kubota, Midori Ishii, Keisuke Akaike, Tsutomu Fujimura, Eisuke Kobayashi, Takashi Yao, Marc Ladanyi, Kazuo Kaneko, Tsuyoshi Saito	14
16	Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors 2016 ·Modern Pathology ·Midori Ishii, Keisuke Akaike, Yoshiyuki Suehara, Kenta Mukaihara, Daisuke Kubota, Shinji Kohsaka, Taketo Okubo, Keiko Mitani, Kaoru Mogushi, Tatsuya Takagi, Kazuo Kaneko, Takashi Yao, Tsuyoshi Saito	16
17	Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases 2015 ·PLoS ONE ·Tatsuya Takagi, Hirohisa Katagiri, (unknown), Yoshiyuki Suehara, Daisuke Kubota, Keisuke Akaike, Midori Ishii, Kenta Mukaihara, Taketo Okubo, Hideki Murata, Mitsuru Takahashi, Kazuo Kaneko, Tsuyoshi Saito	39
18	TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients 2015 ·Molecular and Clinical Oncology ·Tsuyoshi Saito, Keisuke Akaike, Aiko Kurisaki‐Arakawa, Midori Ishii, Kenta Mukaihara, Yoshiyuki Suehara, Tatsuya Takagi, Kazuo Kaneko, Takashi Yao	21
19	TERT promoter mutations are a rare event in gastrointestinal stromal tumors 2015 ·SpringerPlus ·Keisuke Akaike, Midori Ishii, Yoshiyuki Suehara, Kenta Mukaihara, Daisuke Kubota, Keiko Mitani, Tatsuya Takagi, Kazuo Kaneko, Takashi Yao, Tsuyoshi Saito	5
20	The posterior inferior cerebellar artery originating from the internal carotid artery, associated with multiple aneurysms 1991 ·Neuroradiology ·H. Manabe, Nobuhiro Oda, Midori Ishii, Akira Ishii	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact